Anthony G. Quinn

SYRE

Anthony G. Quinn serves as President & CEO at Spyre Therapeutics, Inc. (SYRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$667.6K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$667.6K

Companies Traded

SYRE

Active Period

Dec 2021 – Mar 2022

3 total trades

Most Recent

Buy SYRE

Mar 18, 2022 · $187.7K

Anthony G. Quinn's Insider Trading at Spyre Therapeutics, Inc. (SYRE)

Buys

3 · $667.6K

Sells

0 · $0.00

Total Shares Bought

278,379

Total Shares Sold

SYRE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 18, 2022	Buy	80,079	$2.34	$187.7K	550,540
Mar 15, 2022	Buy	144,666	$1.94	$280.9K	473,461
Dec 13, 2021	Buy	53,634	$3.71	$199.0K	328,795

Related Insiders

Scott L Burrows

officer: Chief Financial Officer

SYRESell · Jul 2, 2026

Sheldon Sloan

officer: Chief Medical Officer

SYRESell · Jul 2, 2026

Cameron Turtle

director, officer: Chief Executive Officer

SYRESell · Jul 2, 2026

Fairmount Funds Management LLC

director

SYRESell · Jun 23, 2026

HENDERSON MICHAEL THOMAS

director

SYRESell · Jun 23, 2026

Explore More Insider Trading Data

SYRE Insider Trading Activity

View all insider trades at Spyre Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity